Welcome to our dedicated page for CHRISTINA LAKE CANNABIS news (Ticker: CLCFF), a resource for investors and traders seeking the latest updates and insights on CHRISTINA LAKE CANNABIS stock.
Christina Lake Cannabis reports developments tied to its licensed Canadian cannabis cultivation, processing, and research operations. The company produces outdoor flower, extracts, and distillate for a B2B client base and operates cultivation and processing assets in British Columbia, including outdoor grow space, propagation and drying rooms, research facilities, greenhouses, and extraction infrastructure.
Recurring news covers financial-statement filings and related management cease trade order updates, operating performance, product mix, cultivation capacity, and supply-chain expansion following the Midway acquisition. Company announcements also address financing arrangements, equipment leases, asset dispositions involving non-core land, working-capital needs, and Health Canada licensing for standard cultivation, processing, and research and development activities.
Christina Lake Cannabis (CLCFF) has entered a non-binding letter of intent for a second potential transaction involving the sale of substantially all of its assets to Medical Saints Ltd. for an aggregate cash purchase price of $18,000,000 on a cash-free, debt-free basis.
This Alternative Transaction would transfer most operating assets, including land, buildings, equipment, inventory, intellectual property and customer data, while excluding cash, cash equivalents, tax receivables and certain other assets to be agreed. The Second LOI, effective September 11, 2026, provides for a $2,000,000 advance payable on signing a definitive agreement, which may be retained by the Company as liquidated damages in specified failure-to-close scenarios. It also includes a 40-day exclusivity period, subject to the Board’s fiduciary duties and to obligations under an earlier LOI for a separate $15,000,000 share-purchase proposal. A Special Committee is evaluating both non-binding offers, and no definitive agreement has been approved.
Christina Lake Cannabis (CSE: CLC, OTCQB: CLCFF) has signed a non-binding letter of intent dated August 20, 2026 with a private Alberta purchaser for a Proposed Transaction under which the purchaser would acquire 100% of the Company’s common shares. The LOI contemplates an aggregate Transaction Value of $15,000,000 for all equity on a fully diluted, cash-free, debt-free basis. Cash payable to shareholders would equal the Transaction Value minus all outstanding debt and transaction expenses, allocated pro rata, so the per-share amount will be disclosed later in a circular. The LOI grants a 120‑day exclusivity period, includes customary Superior Proposal carve‑outs, and anticipates a plan of arrangement or similar structure effective October 30, 2026, subject to due diligence, a definitive agreement, board, shareholder, court, and CSE approvals.
Christina Lake Cannabis (CSE: CLC / OTCQB: CLCFF / FRA: CLB) completed the sale of 99 acres of non-core bare land at 46 Ponderosa Drive in Christina Lake, British Columbia for aggregate gross proceeds of $551,000 on Jan 16, 2026. The land was classified as non-core following the February 2024 Midway acquisition, which the company says provides sufficient land for long‑term objectives. Proceeds will be used for general working capital. Management states the disposition strengthens the balance sheet and enhances liquidity while allowing focus on core operating assets.
Christina Lake Cannabis (OTCQB: CLCFF; CSE: CLC) announced a related‑party secured revolving credit facility and an equipment lease with an entity controlled by director Mervin Boychuk on Oct 20, 2025.
The Facility provides up to $1,500,000, has a two‑year term, bears 15% annual interest, is repayable on demand with 30 days’ notice, is non‑convertible, and is secured by a second mortgage on 775 Highway 395, Christina Lake and a general security agreement.
The Lease Agreement runs 18 months at $4,683.39/month plus GST with a post‑term purchase option. The company relies on MI 61‑101 exemptions for related‑party relief.
Christina Lake Cannabis (CSE: CLC) has announced the filing of its audited financial statements, management discussion and analysis, and CEO/CFO certifications for the fiscal year ended February 28, 2025 on SEDAR+.
Following this filing, the company expects the management cease trade order issued on July 2, 2025, to be revoked, which will allow directors and officers to resume trading in company securities.
Christina Lake Cannabis (CSE: CLC) has announced a delay in filing its annual financial statements for the year ended February 28, 2025. The company will miss the June 30, 2025 filing deadline due to extended audit requirements and resource constraints.
The delay is primarily attributed to increased testing needs for inventory and biological assets, complicated by higher production levels and new product lines following the Midway acquisition. The company expects to file by July 14, 2025 and has applied for a Management Cease Trade Order (MCTO) that would restrict trading by the CEO and CFO until the filings are complete.
Christina Lake Cannabis (CLCFF) has provided a business update highlighting significant expansion and operational developments in 2024. The company acquired a new outdoor cultivation facility in Midway, British Columbia, increasing its cultivation footprint by approximately 100 acres. The combined harvest from both Christina Lake and Midway sites yielded about 105,000 kilograms of extraction grade biomass and flower, contributing to an 81% increase in inventory value as of November 30, 2024.
Financial highlights include a 16% revenue increase, with only a 1% increase in Cost of Goods Sold, resulting in a 7.9% improvement in gross margin. The company completed a non-brokered private placement raising $3,108,375 through the issuance of 94,193,182 common shares. Notable expense increases included salaries (41%), repairs and maintenance (48%), and regulatory fees (139%). The company carries $9,292,924 in Convertible Debenture liabilities and plans to focus on debt reduction in 2025.
Christina Lake Cannabis Corp. (CLC) has announced the filing of its Q1 financial statements for the period ending February 29, 2024, on SEDAR. The filings include the management discussion and analysis and CEO/CFO certifications. The management cease trade order from April 3, 2024, has been revoked, allowing company directors and officers to trade CLC securities again.
Christina Lake Cannabis (CLC) has filed its audited financial statements, management discussion, and analysis for the year ended November 30, 2023, on SEDAR. This follows a series of news releases and aims to lift the management cease trade order granted on April 3, 2024. The company anticipates that directors and officers will soon be permitted to trade its securities. CLC also plans to file its interim financial statements for the period ended February 28, 2024, by June 24, 2024.
Christina Lake Cannabis Corp. (CLCFF) has provided an update on the status of its Management Cease Trade Order (MCTO) issued by the British Columbia Securities Commission (BCSC) on April 3, 2024. The MCTO restricts the trading activities of the CEO and CFO until the company files its audited financial statements for the fiscal year ending November 30, 2023, along with the related management's discussion and analysis and certificates. There are no material changes or defaults since the last announcement. The company expects to file the required documents by June 17, 2024. Following this, the financial statements for Q1 2024 will be filed within five business days. Additionally, Vice President of Sales and Marketing, Milan Stefancik, has left his position effective immediately.